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Abstract
Stella is a developmentally regulated gene highly expressed in mouse embryonic stem (ES) cells and in primordial germ cells
(PGCs). In human, the gene encoding the STELLA homologue lies on chromosome 12p, which is frequently amplified in
long-term cultured human ES cells. However, the role played by STELLA in human ES cells has not been reported. In the
present study, we show that during retinoic acid (RA)-induced differentiation of human ES cells, expression of STELLA
follows that of VASA, a marker of germline differentiation. By contrast, human embryonal carcinoma cells express STELLA at a
higher level compared with both karyotypically normal and abnormal human ES cell lines. We found that over-expression of
STELLA does not interfere with maintenance of the stem cell state of human ES cells, but following retinoic acid induction it
leads to up-regulation of germline- and endodermal-associated genes, whereas neural markers PAX6 and NEUROD1 are
down-regulated. Further, STELLA over-expression facilitates the differentiation of human ES cells into BE12-positive cells, in
which the expression of germline- and endodermal-associated genes is enriched, and suppresses differentiation of the
neural lineage. Taken together, this finding suggests a role for STELLA in facilitating germline and endodermal
differentiation of human ES cells.
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Introduction
Stella/Dppa3/PGC7 was originally identified in mouse pre-
implantation embryos, PGCs and developing germ cells, where it
localizes in both nucleus and cytoplasm [1,2]. The protein is very
basic with an isoelectric point of about 9 and a molecular weight of
about 17 kilodalton. It has been proposed to carry both putative
nuclear import and export signaling domains, a SAP-like domain
and a splicing factor motif-like domain, suggesting that the protein
might participate in regulation of chromatin and/or RNA binding
[1,2]. Surani and colleagues have shown that, in the mouse, Stella
expression is repressed in the post-implantation epiblast, and re-
established again at a high level in PGCs at E7.25, and that the
expression of homeobox genes, Hoxa1 and Hoxb1, is down-
regulated in Stella-positive PGCs compared with Stella-negative
cells [2,3]. This finding implies that PGCs have undergone the
germ cell specification program with a similar timing to the
repression of somatic cell program. However, in mouse embryos,
although emerging PGCs of the post-implantation embryo up-
regulate Stella expression, it is not required for PGC specification.
In addition, Stella-null pups are viable. Nevertheless, Stella-null
female mice show a reduction in fertility because Stella is required
as a maternal inheritance factor in oocytes [3,4]. The role of Stella
in maternal effect inheritance is supported by its high expression in
oocytes [1]. Interestingly, Nakano and colleagues have found that
maternally inherited Stella in the zygote prevents global, active
DNA demethylation of the maternal genome, while the paternal
genome undergoes genome-wide active DNA demethylation
emphasizing the function of Stella in survival of embryos by safe-
guarding the maternal genome, particularly at genomic imprinted
loci [5].
The role of Stella beyond the zygotic stage of developing mouse
embryos is poorly understood. Until recently, Stella expression
status has been linked to choices of differentiation of mouse
embryonic stem (ES) cells [6]. Stella-positive and -negative mouse
ES cells are interchangeable reflecting the naı̈ve and primed states
of mouse pluripotent stem cells, respectively. Specifically, Stella-
negative mouse ES cells show a gene expression profile similar to
that of mouse epiblast stem cells. In addition, Stella-negative ES
cells acquire a higher propensity for neural and trophectoderm
differentiation compared with Stellahigh ES cells. This differentia-
tion bias is supported by an up-regulation of Pax6 and Cdx2, which
are the master regulators of neural and trophoblast differentiation,
respectively, in Stella-negative ES cells. Hence, Stella might possess
a significant functional role in suppressing differentiation of mouse
ES cells toward neuroectodermal and trophectodermal lineages
[6].
The human STELLA gene homologue is located on chromo-
some 12p13, and lies between GDF3 and NANOG, both which are
highly expressed in ES and embryonal carcinoma (EC) cells
[7,8,9]. However, in contrast to mouse ES cells in which the Stella
promoter is demethylated allowing a high expression level of the
gene to be transcribed, the STELLA promoter in human ES cells
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has been shown to be methylated, like that of mouse epiblast stem
cells [6,10]. Similar to PGC specification of mouse embryos,
STELLA is up-regulated during a directed germ cell differentiation
of human ES cells [11], and is co-expressed with VASA, a definitive
germ cell marker, in germ cell differentiating conditions [12].
Therefore, STELLA up-regulation in differentiating human ES
cells might indicate the appearance of an in vitro counterpart of
human PGCs. Interestingly, the genomic region of 12p13 is
frequently duplicated in long-termed culture of human ES cells
[13,14], and also in human EC and seminoma cells [15,16].
Although EC and seminoma cells share many characteristics,
studies of gene expression profile between the two types of
testicular germ cell tumor have shown distinguishing features.
Specifically, high expression of STELLA and SOX2 is observed in
EC cells compared with seminoma and vice versa for SOX17
[8,17,18,19]. In fact, SOX17 has been proposed as a useful marker
to distinguish seminoma from EC cells [17] and is down-regulated
in differentiated seminoma cell line TCam-2 [20,21]. Since the
chromosomal gain of this region is a hallmark of EC and
seminoma cells, amplification of this region might therefore
provide a selective advantage to the so-called culture adapted
human ES cells. Whether STELLA gain-of-function plays an
important role in survival of culture adapted human ES cells has
not been described.
In this study, we report the role of STELLA in facilitating early
germ cell and endodermal differentiation of human ES cells. We
found that over-expression of STELLA does not promote
maintenance of the stem cell state of human ES cells. On the
other hand, similar to mouse ES cells, STELLA over-expression
suppresses expression of trophectodermal- and neural-associated
genes, while germline- and endodermal-associated genes are up-
regulated during induced differentiation. Further, STELLA over-
expression facilitates the generation of cells expressing the surface
antigen, BE12 [22], which might represent cells of an early germ
cell developmental stage and endodermal lineage. These results
support a role for STELLA in supporting the germ cell and
endoderm differentiation programmes of human ES cells.
Results
We first investigated the expression profile of STELLA in human
ES cells and during their differentiation induced by all-trans-
retinoic acid (RA). The expression of STELLA was low in
undifferentiated human ES cells, but it was up-regulated, together
with VASA and ZP1, during differentiation, while OCT4 was
repressed (Figure 1A). AID; a gene that has been reported to be
highly expressed in both ES cells and PGCs [23], was down-
regulated during day 4 and day 7 of differentiation. Its expression
was then briefly up-regulated again on day 14. Expression of
PAX6, a neural commitment gene known to be induced by RA,
was also activated in RA-induced differentiation, consistent with
somatic differentiation towards neural cells. Since the gene
encoding STELLA is located on chromosome, in the region
12p13, which is frequently subject to amplification during culture
adapted human ES cells, and in EC cells [13,14], we also assessed
expression STELLA in karyotypically normal versus abnormal
human ES cells together with human EC cells N2102Ep and
NTERA2 (NT2/D1). We found that human EC cells express
STELLA at a significantly higher level compared with human ES
cells, in which expression was low, whether or not they carried
karyotypic abnormalities including gain of chromosome 12 (Figure
1B). This difference in STELLA expression might reflect the origin
of EC cells from PGC.
To ascertain whether STELLA expression influences the
undifferentiated and/or differentiated state of human ES cells,
we transfected two human ES cell lines, H7 (46,XX) and Shef3
(46,XY), with a plasmid containing STELLA coding sequence
with HA tag at its N-terminus driven by CAG promoter [24] to
establish human ES cells over-expressing STELLA. Control cell
lines of H7 and Shef3 were established using a CAG plasmid over-
expressing Tomato fluorescent protein as to assess the transfection
and selection of stable cell lines by puromycin. Western blot
analysis using anti-HA antibody showed that the human ES cell
lines transfected with the STELLA-HA-tag vector did indeed over-
express STELLA, whereas control lines transfected to over-express
the Tomato fluorescent protein do not express the transgene
(Figure 2A). Immunostaining of HA tag also revealed an over-
expression of exogenous STELLA in ES cells (Figure 2B).
Clongenicity assays were then performed to determine whether
STELLA influences the stem cell state of human ES cells.
However, over-expression of STELLA did not affect cloning
efficiency of human ES cells (Figure 2C). Consistent with this, the
pattern of expression of surface antigens characteristic of the
undifferentiated cells, or their differentiated derivatives, was
unaffected by over expression of STELLA in cultures maintained
under stem cell conditions (Figure 3).
By contrast, over expression of STELLA did affect the pattern
of differentiation observed after RA-induction. In the control cells,
expressing Tomato, the expression of stem cell markers SSEA-3,
SSEA-4 and TRA-1-60 declined 7 days after initial exposure to 10
mM RA, whereas the expression of cell surface antigens
characteristic of neural differentiation, A2B5 (ganglioside GT3),
B159, VINIS56 (ganglioside GD3), VIN2Pb22 (ganglioside GD2),
and B159 (NCAM) was induced (Figure 4) [25]. However, the
STELLA over-expressing cells showed a higher number of cells
expressing SSEA-4 and TRA-1-60, and also gave rise to more cells
expressing the novel surface antigen, BE12,compared with the
control cell lines (Figure 4). On the other hand, the STELLA over-
expressing ES cells produced fewer cells expressing the markers of
neural differentiation, A2B5, VINIS56, VIN2Pb22, and B159.
This suggested that expression of STELLA altered the lineage bias
of the ES cells away from neural differentiation towards lineages
marked by the surface marker BE12.
BE12 is a novel monoclonal antibody produced by a hybridoma
that was generated after using human ES cells for immunization,
but that reacts more strongly with human EC and endodermal cell
lines [22]. To characterise the developmental lineage(s) marked by
BE12, and to test whether these might represent germ cell and/or
endodermal lineages, we analysed the expression of several genes
in cells sorted for BE12 expression from day 7 RA-induced human
ES cultures. The BE12-positive cells expressed STELLA, PRDM14,
PRMT5, DND1, VASA, SCP3, SOX17, SOX7 and AFP, genes found
in both germ cell and endodermal lineages [23,26,27,28,29,30], at
a higher level than BE12-negative cells (Figure 5). By contrast, the
expression of GATA6 and PAX6, which are the master regulators of
extraembryonic endodermal and neural lineages, respectively, was
lower in the BE12-positive cells than in the BE12-negative cells.
These results suggest that the BE12-positive cells induced by
STELLA over-expression may represent both early germline and
definitive endodermal cells.
Consistent with the assays for clonogenicity and antigen
expression, the over expression of STELLA in the undifferentiated
culture of human ES cells did not affect the expression of stem cell-
associated genes OCT4 and NANOG (Figure 6A), although the
trophectoderm associated gene, GCM1, was down-regulated
suggesting that STELLA might inhibit spontaneous trophoecto-
dermal differentiation in these cultures. On the other hand, genes
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expressed in germline and endodermal cells, including VASA, AID,
SOX17 and AFP, were up-regulated after RA-induced differenti-
ation, whereas neural markers PAX6 and NEUROD1 were down-
regulated in cells over-expressing STELLA, in comparison to
control cells (Figure 6B). Collectively, these results indicate that
STELLA does not promote maintenance of stem cell state of
human ES cells, but rather influences fate determination towards
germ cell and endodermal lineages upon induction of differenti-
ation.
Figure 2. Establishment of STELLA over-expression cell lines from human ES cells. Clones of human ES cells over expressing the
fluorescent protein ‘Tomato’ or HA-tagged STELLA were isolated after transfection with vectors encoding Tomato or HA-STELLA under the control of
the CAG constitutive promoter. (A) Western blot analysis of HA tag in human ES cells H7 and Shef3 over-expressing Tomato or HA-tagged STELLA. (B)
Immunostaining of ectopically expressed STELLA using HA tag antibody. (C) STELLA over-expression does not influence clonal ability of human ES
cells. Colony number was counted and reported as percent cloning efficiency. Data are shown as mean6SD; n = 3.
doi:10.1371/journal.pone.0056893.g002
Figure 1. Expression of STELLA during the differentiation of human ES cells. (A) STELLA expression is up-regulated during RA-induced
differentiation of human ES cells. RT-qPCR analysis was performed for genes specifically expressed in undifferentiated stem cells (OCT4), neural
differentiation (PAX6) and germ cells (STELLA, VASA, AID and ZP1) during RA-induced differentiation of human ES cells. (B) Human EC cells highly
express STELLA compared with human ES cells. RT-qPCR was used to test STELLA expression in normal and karyotypically abnormal sublines of human
ES celllines, H7.s14 [46,XX], H7.s6 [47,XX, +1, der(6)t(6;17)(q27;q1)], H7.SHO [48,XX,+1,der(6)t(6;17)(q27;q1),+8], H14.s9 [46,XY] and H14.BJ1 [47,XY,
+12], and in human EC cell lines NT2/D1 and N2102Ep. Cytogenetic analysis of the latter two cell lines has been described elsewhere [9]. Data are
shown as mean6SD; n = 3.
doi:10.1371/journal.pone.0056893.g001
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Discussion
In this study, we found that the pattern of STELLA expression
during RA-induced differentiation of human ES cells follows that
of VASA expression and other genes associated with the germ line
(Figure 1A). This gene expression pattern supports the notion of
germline differentiation of human ES cells following RA induction
[12], and suggests that the activation of STELLA is an early event
of germ cell differentiation of human ES cells.
Although Stella is highly expressed in mouse ES cells [6,8], and
in human EC cells (Figure 1B), the over-expression of STELLA in
human ES cells does not promote clongenicity of human ES cells
(Figure 2C and 3). Gain of the short arm of chromosome 12,
which harbors STELLA as well as the stem cell-associated gene
NANOG, is common in both human EC cells and in long-term
cultured human ES cells [13,14]. However, our results suggest the
selective advantage thought to associated with gain of chromo-
some 12 is not dependent upon the over-expression of STELLA.
On the other hand, STELLA over-expression results in more cells
expressing the surface antigen, BE12, and less cells with neural
markers in RA-induced human ES cell differentiation than the
control (Figure 4). The BE12 cell surface antigen is particularly
strongly expressed by some human EC and yolk sac carcinoma cell
lines but only weakly and sporadically by human ES cells [22]. In
the current study, we found that BE12-positive human ES cells
may represent early germline and definitive endoderm differen-
tiation. The expression of BE12 in human EC cells might reflect
their origin from primordial germ cells, and perhaps less than
complete reversion to an embryonic state resembling that of
human ES cells. Further characterization of BE12-positive cells
derived from human ES culture in more detail might provide a
new tool to study germline and endodermal differentiation of
human ES cells.
That over-expression of STELLA leads to the repression of
genes and surface antigens associated with trophectodermal and
neural differentiation, but enhances the the expression of genes
associated with definitive endoderm and the germline suggests a
role for STELLA in lineage selection of human ES cells. Our
results are therefore consistent with the finding from Surani and
colleagues, which shows that mouse ES cells with a higher level of
Stella expression exhibit a lower expression level of trophectoder-
mal and neural markers than those with a lower level of Stella
expression [6].
Figure 3. Expression of cell surface markers in human ES cells over-expressing STELLA. Flow cytometric analysis of various surface
antigens characteristic of human ES cells or their differentiated derivatives in human ES cells, H7 and Shef3, transfected with Tomato or with STELLA.
The expression of these marker antigens was not affected by STELLA over-expression.
doi:10.1371/journal.pone.0056893.g003
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A strong up-regulation of Stella has been observed in mouse
PGCs after specification from post-implantation epiblast [2].
Although not required for PGC differentiation and survival in
mice [3,4], its function in the germline might be to directly
promote expression of germ cell-associated genes and/or to
suppress trophectodermal and somatic programs through its DNA
binding domain [31]. Another possible function of Stella in the
germline might be to prevent active DNA demethylation at loci
other than imprinted genes during the erasure of genomic
imprinting status in PGCs [32], since it protects maternal genome
from DNA demethylation in the zygote [5]. The increase in AID
expression of differentiated human ES cells over-expressing
STELLA might therefore mimic the PGC reprogramming event,
because AID is implicated in active DNA demethylation process
[33,34]. Since human ES cells have been proposed to be similar to
mouse epiblast stem cells [35,36], it would be of interest to test
whether over-expression of Stella in mouse epiblast stem cells will
result in germline and/or endodermal differentiation. In fact, up-
regulation of Stella in mouse epiblast stem cells during germline
differentiation has been described elsewhere [29]. Furthermore,
DAZL and BOULE, which are highly expressed in the germline,
have been shown to promote in vitro generation of PGCs from
human ES cells [12]. Therefore, an over-expression of STELLA in
human pluripotent stem cells together with those germline
inducing genes might synergistically facilitate differentiation of
the stem cells toward germ cell lineage.
Materials and Methods
Cell culture
Human ES cell lines H7 and Shef3 [7,37] were grown in
Knockout-DMEM supplemented with 20% Knockout-Serum
Replacement, 1X non-essential amino acids, 1 mM glutamine,
0.1 mM beta-mercaptoethanol and 4 ng/ml bFGF (Invitrogen)
seeded on 66103 cells/cm2 mitomycin C-treated MF-1 mouse
embryonic fibroblasts (MEFs), and cultured at 37uC under a
humidified atmosphere of 5% CO2 in air. Cells were passaged
every 5–7 days using collagenase type IV (Invitrogen) and scraping
with glass-beads (Sigma). To induce differentiation of human ES
cells, the culture medium was supplemented with 10 mM of all-
trans-retinoic acid (Sigma).
Figure 4. Expression of cell surface markers during RA-induced differentiation of human ES cells over-expressing STELLA. Human ES
cell lines H7 and Shef3 over-expressing Tomato or STELLA were induced to differentiate by 10 mM RA for 7 days. Expression of surface markers was
determined by flow cytometry. STELLA over-expression facilitates generation of BE12-positive cells and tends to inhibit generation of differentiated
cells expressing antigens characteristic of neural differentiation (A2B5, VINIS56 and VIN2PB22, recognnising gangliosides GT3, GD3 and GD2, and
B159, recognizing NCAM) (.
doi:10.1371/journal.pone.0056893.g004
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Construction of human ES cells over-expressing STELLA
cDNA encoding the human STELLA homologue was amplified
using One-Step RT-PCR kit (Invitrogen). A haemagglutinin (HA)
sequence tag-containing primer was used to add the HA tag at the
5’-position of the cDNA to allow detection of the transgene by
staining the HA tag. The HA-STELLA DNA fragment was gel-
purified using a DNA extraction kit from Fermentas. The Tomato
encoding gene of pCAG-Tomato-IRES-puromycin [38] was
excised using XhoI and NotI, and was replaced by the HA-
STELLA DNA fragment. The plasmid pCAG-HA-STELLA-
IRES-puromycin was then transfected into either H7 or Shef3 to
establish the STELLA over-expressing cell lines using electropo-
ration. Briefly, human ES cells were dissociated using 0.05 %
trypsin. One million human ES cells were then transfected with
5 mg PmlI-linearized plasmid DNA. pCAG-Tomato-IRES-puro-
mycin was also separately transfected in the parental H7 and
Shef3 to construct control cell lines. The transfectants were
immediately plated on MEFs with human ES culture medium.
One week after the transfection, 1 mg/ml puromycin was added to
the culture medium to select human ES cell colonies which were
resistant to the antibiotic. RT-qPCR and immunofluorescence
staining were employed to test STELLA over-expression in the
human ES cell lines. STELLA over-expressing clones of human
ES cell lines H7 and Shef3 that show the highest expression level
of STELLA transgene were investigated in further experiments.
Reverse transcription quantitative polymerase chain
reaction (RT-qPCR)
RNA was extracted using TRIzol reagent (Invitrogen). Com-
plementary DNA synthesis was performed with 1 mg RNA. qPCR
was carried on by using SYBR Green JumpStart Taq ReadyMix
(Sigma) in a total volume of 20 ml each well with an iCycler iQ
system (Biorad). Gene expression was normalized by expression
level of ACTB. Primer sequences are available upon request.
Immunofluorescence staining
Cells were grown in a 24-well chamber until nearly confluent,
and were fixed with 4% PFA. Fixed cells were permeabilized with
0.5% Triton-X 100, and were incubated with an antibody against
rabbit anti-HA tag (Abcam). A secondary antibody conjugated
with FITC (Santa Cruz) was then used for visualization under an
InCell Analyzer fluorescence microscope workstation system (GE
Healthcare).
Figure 5. Gene expression of BE12-positive cells. Human ES cells
were induced to differentiate by 10 mM RA for 7 days. Differentiated
cells were trypsinized and stained for BE12. BE12 positive and negative
cells were isolated by Fluorscence Activarted Cell Sorting, and were
subjected to RT-qPCR analysis. Expression of genes associated with
germ cell and endodermal lineages was enriched in BE12-positive cells.
Data are shown as the mean6SD; n = 3.
doi:10.1371/journal.pone.0056893.g005
Figure 6. Differential gene expression of human ES cells
expressing STELLA.(A) RT-qPCR analysis of human ES cells over-
expressing STELLA grown under undifferentiated condition. STELLA
over-expression suppresses expression of a trophectodermal gene
GCM1. (B) RT-qPCR analysis of RA-induced human ES cells over-
expressing STELLA. STELLA induces genes involved in germ cell
development VASA and AID, but suppresses expression of neural
differentiation genes PAX6 and NEUROD1. Data are shown as mean6SD;
n = 3.
doi:10.1371/journal.pone.0056893.g006
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Flow cytometry and cell sorting
Flow cytometry was performed as previously described
[22,25,39]. Briefly, cultured cells were harvested by trypsinization.
One hundred thousand cells in 100 ml PBS with 10% FCS were
incubated with primary monoclonal antibodies including P3X
(negative control), SSEA-3, SSEA-4, TRA-1-60, SSEA-1, BE12,
A2B5, B159, Vinis56 and Vin2Pb22 at 1:10 dilution for 30 min
[25]. Cells were washed and incubated with FITC-conjugated
secondary antibody (Jackson Laboratory). Cell surface expression
was analyzed by a Cyan bench-top flow cytometer (Dako
Cytomation). To isolate BE12-positive and –negative populations
107 human ES cells were incubated with BE12 antibody at 1 10
dilution in 10 ml PBS with 10% FCS. The cells were washed,
incubated with the secondary antibody for 30 min, and were
sorted by a Moflo flow cytometer system (Dako Cytomation) into
1 ml PBS with 10% FCS. The sorted cells of both negative and
positive BE12 populations were extracted for RNA using Trizol
(Invitrogen).
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